TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
ACHIM Biotherapeutics AB
Closing information (x1000 SEK)
| Closing information | 2025/06 | 2024/06 | 2023/06 |
| Turnover |
2
|
0
|
0 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-203
|
-192
|
-330 |
| EBITDA |
-203
|
-192
|
-330 |
| Total assets |
193
|
151
|
253 |
| Current assets |
193
|
151
|
253 |
| Current liabilities |
39
|
69
|
79 |
| Equity capital |
153
|
80
|
172 |
| - share capital |
112
|
150
|
150 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2025/06 | 2024/06 | 2023/06 |
| Solvency |
79.3%
|
53.0%
|
68.0% |
| Turnover per employee |
2
|
0
|
0 |
| Profit as a percentage of turnover | -10150.0% | ||
| Return on assets (ROA) |
-105.2%
|
-127.2%
|
-130.4% |
| Current ratio |
494.9%
|
218.8%
|
320.3% |
| Return on equity (ROE) |
-132.7%
|
-240.0%
|
-191.9% |
| Change turnover |
2
|
0
|
-845 |
| Change turnover % | -100% | ||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/06 | 2024/06 | 2023/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.